MEDIFAST INC (MED): Price and Financial Metrics


-0.47 (-0.40%)

POWR Rating

Component Grades














  • MED scores best on the Quality dimension, with a Quality rank ahead of 97.34% of US stocks.
  • The strongest trend for MED is in Quality, which has been heading up over the past 177 days.
  • MED's current lowest rank is in the Growth metric (where it is better than 14.86% of US stocks).

MED Stock Summary

  • MEDIFAST INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 96.96% of US listed stocks.
  • The ratio of debt to operating expenses for MEDIFAST INC is higher than it is for about merely 7.92% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MED comes in at 16.25% -- higher than that of 90.83% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEDIFAST INC are VRTV, MAN, SPTN, OMI, and RYI.
  • Visit MED's SEC page to see the company's official filings. To visit the company's web site, go to

MED Valuation Summary

  • MED's price/earnings ratio is 8.3; this is 36.15% lower than that of the median Consumer Cyclical stock.
  • MED's price/earnings ratio has moved down 4.7 over the prior 243 months.

Below are key valuation metrics over time for MED.

Stock Date P/S P/B P/E EV/EBIT
MED 2023-01-26 0.8 8.3 8.3 6.1
MED 2023-01-25 0.8 8.3 8.3 6.1
MED 2023-01-24 0.8 8.2 8.2 6.0
MED 2023-01-23 0.8 8.7 8.7 6.4
MED 2023-01-20 0.8 8.6 8.6 6.3
MED 2023-01-19 0.8 8.5 8.4 6.2

MED Growth Metrics

    The 2 year cash and equivalents growth rate now stands at 30.15%.
  • The 4 year net income to common stockholders growth rate now stands at 283.59%.
  • Its 5 year price growth rate is now at 86.51%.
MED's revenue has moved up $925,493,000 over the prior 33 months.

The table below shows MED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,639.165 135.372 151.072
2022-06-30 1,662.162 95.776 156.899
2022-03-31 1,603.018 72.892 164.749
2021-12-31 1,526.087 94.545 164.031
2021-09-30 1,413.165 121.833 158.002
2021-06-30 1,271.24 147.147 150.473

MED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MED has a Quality Grade of A, ranking ahead of 99.43% of graded US stocks.
  • MED's asset turnover comes in at 4.143 -- ranking 1st of 59 Food Products stocks.
  • TWNK, TOFB, and KHC are the stocks whose asset turnover ratios are most correlated with MED.

The table below shows MED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 4.143 0.744 19.148
2021-03-31 4.006 0.739 72.885
2020-12-31 3.851 0.746 8.172
2020-09-30 3.779 0.746 4.378
2020-06-30 3.670 0.745 2.384
2020-03-31 3.596 0.753 1.821

MED Price Target

For more insight on analysts targets of MED, see our MED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $363.33 Average Broker Recommendation 1.33 (Strong Buy)

MED Stock Price Chart Interactive Chart >

Price chart for MED

MED Price/Volume Stats

Current price $115.84 52-week high $200.82
Prev. close $116.31 52-week low $96.00
Day low $114.59 Volume 170,400
Day high $118.46 Avg. volume 151,378
50-day MA $118.00 Dividend yield 5.66%
200-day MA $140.71 Market Cap 1.27B


Medifast Inc. is a manufacturer and provider of clinically weight-loss and weight-maintenance products and programs. The company was founded in 1980 and is based in Owings Mills, Maryland.

MED Latest News Stream

Event/Time News Detail
Loading, please wait...

MED Latest Social Stream

Loading social stream, please wait...

View Full MED Social Stream

Latest MED News From Around the Web

Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.

Insiders who placed huge bets on Medifast, Inc. (NYSE:MED) earlier this year would be disappointed with the 6.5% drop

Insiders who bought US$712k worth of Medifast, Inc.'s ( NYSE:MED ) stock at an average buy price of US$139 over the...

Yahoo | January 21, 2023

Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)

In this article we are going to estimate the intrinsic value of Medifast, Inc. ( NYSE:MED ) by taking the expected...

Yahoo | January 4, 2023

Medifast (MED) Banks on OPTAVIA Strength Amid Cost Woes

Medifast (MED) benefits from its OPTAVIA lifestyle solution and coaching support system. However, the gross margin has been declining year over year for a while now.

Yahoo | December 30, 2022

7 Dividend Stocks to Buy and Hold Forever

If you’re a dividend investor these seven dividend stocks to buy and hold forever are worth considering heading into 2023.

Will Ashworth on InvestorPlace | December 21, 2022

7 Undervalued Reddit Stocks to Buy Now

If you are looking for undervalued Reddit stocks to buy, this article will give you eight great options that are trading at a discount.

Faizan Farooque on InvestorPlace | December 20, 2022

Read More 'MED' Stories Here

MED Price Returns

1-mo -0.83%
3-mo 9.15%
6-mo -12.72%
1-year -35.51%
3-year 26.23%
5-year 104.44%
YTD 0.42%
2022 -42.31%
2021 9.36%
2020 86.18%
2019 -9.73%
2018 82.11%

MED Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MED Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.742 seconds.